N. Thomas

Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity

E. R. James, S. Hoffman, C. Loucq, 2011, Science.

Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation

N. Thomas, N. Croft, I. Sanderson, 2007, Gut.

COMPARATIVE SAFETY AND IMMUNOGENICITY OF TWO YELLOW FEVER 17 D VACCINES ( ARILVAX AND YF-VAX ) IN A PHASE III MULTICENTER , DOUBLE-BLIND CLINICAL TRIAL

T. Monath, R. Shope, J. Tian, 2003 .

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

T. Monath, R. Shope, J. Tian, 2002, The American journal of tropical medicine and hygiene.

A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.

M. Finucane, R. Sack, E. Hall, 2008, Vaccine.

Construction and Phase I Clinical Evaluation of the Safety and Immunogenicity of a Candidate Enterotoxigenic Escherichia coli Vaccine Strain Expressing Colonization Factor Antigen CFA/I

J. C. Beavis, N. Thomas, A. Turner, 2006, Infection and Immunity.

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers.

D. Sack, R. Sack, E. Hall, 2006, Vaccine.